Legal & General Group’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-60,868
Closed -$1.78M 3300
2017
Q3
$1.78M Buy
60,868
+973
+2% +$27.3K ﹤0.01% 1640
2017
Q2
$1.57M Buy
59,895
+4,892
+9% +$120K ﹤0.01% 1650
2017
Q1
$1.29M Buy
55,003
+88
+0.2% +$2.17K ﹤0.01% 1705
2016
Q4
$1.38M Buy
54,915
+24,726
+82% +$624K ﹤0.01% 1617
2016
Q3
$844K Buy
30,189
+24,456
+427% +$627K ﹤0.01% 1465
2016
Q2
$140K Hold
5,733
﹤0.01% 1926
2016
Q1
$125K Sell
5,733
-270
-4% -$7.19K ﹤0.01% 1929
2015
Q4
$208K Hold
6,003
﹤0.01% 1730
2015
Q3
$169K Buy
6,003
+1,542
+35% +$51.8K ﹤0.01% 1782
2015
Q2
$150K Hold
4,461
﹤0.01% 1872
2015
Q1
$125K Hold
4,461
﹤0.01% 1898
2014
Q4
$93K Hold
4,461
﹤0.01% 2027
2014
Q3
$110K Buy
+4,461
New +$118K ﹤0.01% 1830

Legal & General Group's PMC Position: Q4 2017 in Review

Legal & General Group sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 60,868 shares — an estimated $1.78M sold.

Legal & General Group first reported a position in PMC in Q3 2014 and held it in 13 quarters. The position peaked at $1.78M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Legal & General Group reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Legal & General Group sold 60,868 PharMerica Corporation shares in Q4 2017, an estimated $1.78M.
  • Legal & General Group first reported a position in PharMerica Corporation in Q3 2014 and held it in 13 quarters.
  • Legal & General Group's PharMerica Corporation position peaked at $1.78M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Legal & General Group's 13F filing for Q4 2017, filed 13 Feb 2018.